Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
In GLP-1 receptor agonist trials, headache occurred in approximately 10-25% of participants, making it one of the more commonly reported neurological adverse events alongside nausea and dizziness
This is a research schedule, not a prescription
New drug delivery systems are needed to handle high-viscosity drugs or higher volumes in a patient-acceptable format. Portals PRIME device can deliver volumes up to 2.0mL at high viscosities (up to 1,200cP) in 0.6 seconds
Among participants without diabetes, cardiovascular risk reduction was consistent across all baseline HbA1c subgroups (less than 5.7%, 5.7% to 6.0%, and 6.0% to 6.5%) and across categories of HbA1c change from baseline to 20 weeks
US$ 28.13
US$ 26.63
US$ 22.84
US$ 29.61
US$ 25.34
US$ 28.03
